Bioreperia is a Swedish company that increases the success rate in clinical trials using zebrafish models.

Many drugs fail at late stages of development due to efficacy or toxicity issues. BioReperia’s services enable early identification of such issues, increasing the speed of pre-clinical development and success-rate of other candidates.